Literature DB >> 19544800

Novel dosimetric phantom for quality assurance of volumetric modulated arc therapy.

Daniel Létourneau1, Julia Publicover, Jakub Kozelka, Douglas J Moseley, David A Jaffray.   

Abstract

The objective of this work is to assess the suitability and performance of a new dosimeter system with a novel geometry for the quality assurance (QA) of volumetric modulated arc therapy (VMAT). The new dosimeter system consists of a hollow cylinder (15 and 25 cm inner and outer diameters) with 124 diodes embedded in the phantom's cylindrical wall forming four rings of detectors. For coplanar beams, the cylindrical geometry and the ring diode pattern offer the advantage of invariant perpendicular incidence on the beam central axis for any gantry angle and also have the benefit of increasing the detector density as both walls of the cylinder sample the beam. Other advantages include real-time readout and reduced weight with the hollow phantom shape. A calibration method taking into account the variation in radiation sensitivity of the diodes as a function of gantry angle was developed and implemented. In this work, the new dosimeter system was used in integrating mode to perform composite dose measurements along the cylindrical surface supporting the diodes. The reproducibility of the dosimeter response and the angular dependence of the diodes were assessed using simple 6 MV photon static beams. The performance of the new dosimeter system for VMAT QA was then evaluated using VMAT plans designed for a head and neck, an abdominal sarcoma, and a prostate patient. These plans were optimized with 90 control points (CPs) and additional versions of each plan were generated by increasing the number of CPs to 180 and 360 using linear interpolation. The relative dose measured with the dosimeter system for the VMAT plans was compared to the corresponding TPS dose map in terms of relative dose difference (% deltaD) and distance to agreement (DTA). The dosimeter system's sensitivity to gantry rotation offset and scaling errors as well as setup errors was also evaluated. For static beams, the dosimeter system offered good reproducibility and demonstrated small residual diode angular dependence after calibration. For VMAT deliveries, the agreement between measured and calculated doses was good with > or = 86.4% of the diodes satisfying 3% of % deltaD or 2 mm DTA for the 180 CP plans. The phantom offered sufficient sensitivity for the detection of small gantry rotation offset (3 degrees) and scaling errors (1 degree) as well as phantom setup errors of 1 mm, although the results were plan dependent. With its novel geometry, the dosimeter system was also able to experimentally demonstrate the discretization effect of the number of CPs used in the TPS to simulate a continuous arc. These results demonstrate the suitability of the new dosimeter system for the patient-specific QA of VMAT plans and suggest that the dosimeter system can be an effective tool in the routine QA and commissioning of treatment machines capable of VMAT delivery and cone-beam CT image guidance.

Entities:  

Mesh:

Year:  2009        PMID: 19544800     DOI: 10.1118/1.3117563

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  34 in total

1.  A comprehensive investigation of the accuracy and reproducibility of a multitarget single isocenter VMAT radiosurgery technique.

Authors:  Andrew Thomas; Michael Niebanck; Titania Juang; Zhiheng Wang; Mark Oldham
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

2.  Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.

Authors:  X Jin; H Yan; C Han; Y Zhou; J Yi; C Xie
Journal:  Br J Radiol       Date:  2014-12-10       Impact factor: 3.039

3.  Independent calculation of monitor units for VMAT and SPORT.

Authors:  Xin Chen; Karl Bush; Aiping Ding; Lei Xing
Journal:  Med Phys       Date:  2015-02       Impact factor: 4.071

4.  Investigation of two linear accelerator head designs for treating brain metastases with hypofractionated volumetric-modulated arc radiotherapy.

Authors:  Mark Ruschin; Arjun Sahgal; Sara Iradji; Hany Soliman; Claudia Leavens; Young Lee
Journal:  Br J Radiol       Date:  2016-04-13       Impact factor: 3.039

5.  Comparison of dosimetric variation between prostate IMRT and VMAT due to patient's weight loss: Patient and phantom study.

Authors:  James C L Chow; Runqing Jiang
Journal:  Rep Pract Oncol Radiother       Date:  2013-06-25

6.  Advantage of 3D volumetric dosemeter in delivery quality assurance of dynamic arc therapy: comparison of pencil beam and Monte Carlo calculations.

Authors:  H-J Shin; J H Song; J-Y Jung; Y-K Kwak; C S Kay; Y-N Kang; B O Choi; H S Jang; S H Son
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

7.  3D VMAT Verification Based on Monte Carlo Log File Simulation with Experimental Feedback from Film Dosimetry.

Authors:  A R Barbeiro; A Ureba; J A Baeza; R Linares; M Perucha; E Jiménez-Ortega; S Velázquez; J C Mateos; A Leal
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

8.  Comparisons of volumetric modulated arc therapy (VMAT) quality assurance (QA) systems: sensitivity analysis to machine errors.

Authors:  Bin Liang; Bo Liu; Fugen Zhou; Fang-Fang Yin; Qiuwen Wu
Journal:  Radiat Oncol       Date:  2016-11-07       Impact factor: 3.481

9.  Investigation on the effect of sharp phantom edges on point dose measurement during patient-specific dosimetry with Rapid Arc.

Authors:  R A Kinhikar; V P Pandey; Rojas K Jose; U Mahantshetty; D S Dhote; D D Deshpande; S K Shrivastava
Journal:  J Med Phys       Date:  2013-07

10.  Three-dimensional radiochromic film dosimetry for volumetric modulated arc therapy using a spiral water phantom.

Authors:  Masao Tanooka; Hiroshi Doi; Hideharu Miura; Hiroyuki Inoue; Yasue Niwa; Yasuhiro Takada; Masayuki Fujiwara; Toshiyuki Sakai; Kiyoshi Sakamoto; Norihiko Kamikonya; Shozo Hirota
Journal:  J Radiat Res       Date:  2013-05-17       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.